Kestrel conducted a market feasibility analysis and worked with the client to develop a commercial exploitation plan for a ground-breaking DNA Extraction and Isolation (DEI) membrane technology
Background:
Extraction of DNA for purification and analysis is widely used in many clinical, diagnostic, research, environmental and pathology applications. In human diagnostics the process can be painful and invasive, requiring direct access to internal organs. Results can also be slow to process, resulting in delays to test results and critical diagnoses
Requirement:
Kestrel’s client had developed a technology that can extract and isolate DNA from small samples circulating in blood. The technology is low-cost, easy to use, and can produce results in 20 minutes.
Kestrel’s task was to identify potential applications, how the technology could be used, and its market potential.
Kestrel were also asked to work with a commercial consultant to develop commercial development routes.
Response:
Kestrel worked closely with the client team to identify KOLs, clinicians and potential development partners including major international biotech companies.
Kestrel identified and contacted key personnel in these organisations to understand where the technology could provide significant benefits, preparing presentation materials to communicate the benefits and developing value propositions.
We identified important new opportunities for the technology in offering near real-time diagnoses in clinics.
Result:
Kestrel set up in-person meetings and established development pathways with several collaboration partners.
The potential market opportunity has been estimated in excess of $50 Bn across several sectors.
Several opportunities are currently under discussion with our client and collaboration partners to create technology evaluation programmes.
The client is progressing spinout and VC funding opportunities with several partners and is considering the development of a stand-alone analysis system based on the technology.